Empreendimentos Pague Menos (PGMN3) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
3 Sep, 2026Executive summary
Achieved record profitability in 2Q26, with EBITDA margin at 6.5% and net income up 22.2% year-over-year, driven by strong same-store sales, operational leverage, and strategic execution.
Same-store sales grew 8.0%, outpacing inflation by 3x, and market share increased to 6.7%, marking the 11th consecutive quarter of above-market growth.
Digital channel sales exceeded R$1 billion, up 40.6% year-over-year, now representing 24.1% of total sales, with active client base reaching 22.6 million.
Recognized as one of the top 10 retail companies to work for in Brazil, emphasizing a people-centric culture and community engagement.
Financial highlights
Gross revenue grew 9.3% year-over-year in Q2 2026 to R$4.34 billion, with a three-year CAGR of 14%.
Adjusted EBITDA rose 15.4% year-over-year to R$281.7 million, with margin at 6.5%.
Net income increased 22.2% year-over-year in Q2, with EPS at R$0.51.
Operating cash flow reached R$188.8 million for the quarter and R$573.4 million over the last 12 months, up 3x year-over-year.
Outlook and guidance
Store openings expected to accelerate as deleveraging continues, with investments in logistics and technology supporting future growth.
Expecting normalization of gross margin pressures and inventory build-up from new distribution center by end of 3Q26.
Strategic focus on market share growth, private label expansion, and continued digital channel improvements.
Latest events from Empreendimentos Pague Menos
- Revenue up 14.4% YoY, net income quadrupled, and digital sales surged to 22.2% of total.PGMN3
Q1 2026 - 2025 saw record revenue, EBITDA, and net income, with market share and digital sales at all-time highs.PGMN3
Q4 2025 - Record 18% revenue growth, 49.6% net income rise, and 6.7% market share in 3Q25.PGMN3
Q3 2025 - Record sales and digital growth drove higher margins, profit, and market share gains.PGMN3
Q2 2025 - Nationwide healthcare platform drives growth through digital innovation and health services expansion.PGMN3
Investor Presentation - Record sales, margin gains, and cash flow driven by Extrafarma synergies and digital growth.PGMN3
Q3 2024 - Revenue and profit surged as growth accelerated, cash flow improved, and market share increased.PGMN3
Q2 2024 - Record revenue, EBITDA, and digital sales drove margin gains and market share growth in 1Q25.PGMN3
Q1 2025 - Record sales, margin expansion, and synergy gains drive robust growth and deleveraging.PGMN3
Q4 2024